Artificial intelligence, machine learning, and deep learning for clinical outcome prediction
Emerging Topics in Life Sciences · 21.12.2021 · 5 (6) · 729-745
DOI: 10.1042/etls20210246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Topics in Life Sciences, online erschienen am 20.12.2021. Verfasst von Rowland W Pettit und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, U.S.A. Die Arbeit wurde bisher 123-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS.
Abstract (Originalsprache)
AI is a broad concept, grouping initiatives that use a computer to perform tasks that would usually require a human to complete. AI methods are well suited to predict clinical outcomes. In practice, AI methods can be thought of as functions that learn the outcomes accompanying standardized input data to produce accurate outcome predictions when trialed with new data. Current methods for cleaning, creating, accessing, extracting, augmenting, and representing data for training AI clinical prediction models are well defined. The use of AI to predict clinical outcomes is a dynamic and rapidly evolving arena, with new methods and applications emerging. Extraction or accession of electronic health care records and combining these with patient genetic data is an area of present attention, with tremendous potential for future growth. Machine learning approaches, including decision tree methods of Random Forest and XGBoost, and deep learning techniques including deep multi-layer and recurrent neural networks, afford unique capabilities to accurately create predictions from high dimensional, multimodal data. Furthermore, AI methods are increasing our ability to accurately predict clinical outcomes that previously were difficult to model, including time-dependent and multi-class outcomes. Barriers to robust AI-based clinical outcome model deployment include changing AI product development interfaces, the specificity of regulation requirements, and limitations in ensuring model interpretability, generalizability, and adaptability over time.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, U.S.A.
- Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, U.S.A.
- Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX, U.S.A.
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, U.S.A.
ORCID-Profile: Rowland W Pettit
Förderung
- NIEHS NIH HHS
Zitieren
APA
Pettit, R. W., Fullem, R., Cheng, C., & Amos, C. I. (2021). Artificial intelligence, machine learning, and deep learning for clinical outcome prediction. Emerging Topics in Life Sciences, 5(6), 729-745. https://doi.org/10.1042/etls20210246
Vancouver
Pettit RW, Fullem R, Cheng C, Amos CI. Artificial intelligence, machine learning, and deep learning for clinical outcome prediction. Emerging Topics in Life Sciences. 2021;5(6):729-745. doi:10.1042/etls20210246
BibTeX
@article{Pettit2021,
author = {Pettit, Rowland W and Fullem, Robert and Cheng, Chao and Amos, Christopher I},
title = {Artificial intelligence, machine learning, and deep learning for clinical outcome prediction},
journal = {Emerging Topics in Life Sciences},
year = {2021},
volume = {5},
number = {6},
pages = {729--745},
doi = {10.1042/etls20210246}
}
EUVIMED